Vein diameter is a predictive factor for recanalization in treatment with ultrasound-guided foam sclerotherapy

Toniolo, J; Chiang, Nathaniel; Munteanu, Diana; Russell, Amy K.; Hao, Huming; Chuen, Jason

doi:10.1016/j.jvsv.2018.05.029

Cited by 8 publications

(8 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The rate of thrombophlebitis on the seventh day postoperative could be associated with inflammation related to the polidocanol sclerotherapy technique. 5 , 33 All four cases of thrombophlebitis in the study had an extra clinical assessment at one month and were asymptomatic for this adverse event. Bruising was not an element of concern among participants, but highly observed in some until the end of the first month.…”

Section: Discussionmentioning

confidence: 94%

Radiofrequency Ablation for Axial Reflux Associated with Foam Sclerotherapy for Varicosities in One-Step Approach: A Prospective Cohort Study Comprising Large Diameters Saphenous Veins

Poschinger-Figueiredo¹,

Virgini-Magalhães²,

Pôrto³

et al. 2021

VHRM

View full text Add to dashboard Cite

Objective This study assessed the outcomes and impact on the quality of life following one-step outpatient radiofrequency ablation (RFA) and ultrasound guided foam sclerotherapy (USGFS) for large reflux with varicosities in the great saphenous vein (GSV). Design Prospective, single-centre, analytical cohort. Materials and Methods Thirty symptomatic patients having reflux in the GSV and varicosities (CEAP C3 to C6) were treated with RFA and USGFS simultaneously, in a single-step procedure, from March 2016 to December 2016. They were followed up at 1 week, 6 months, 1 and 3 years. Clinical outcomes, changes in the Quality of Life (QOL) questionnaires SF-36™, VCSS and AVVQ, evolutive vein occlusion rates were assessed by duplex ultrasound, and ulcer closure was checked. Results The sample was divided into two groups: (Group 1) GSV diameter ≥13.0 mm (median 19.0 [14–24]), 17 subjects, and (Group 2) GSV diameter ≤12.9 mm (median 10.3 [10–12]), 16 subjects. No major adverse event was observed, and the postoperative minor adverse event rates were similar between the two groups. A significant improvement was observed in VCSS and AVVQ from the preoperative levels to the sixth month and the third-year follow-up. Twelve of 13 ulcers had healed at 1 year and remained closed until 3 years. The entire sample had a significant increase in all short form 36 domains, except for mental health in the Group 2 (GSV ≥ 13.0 mm). Overall first week occlusion rate for the whole sample was 90.9% and 69.7% at the 3-year follow-up. No difference in occlusion rate was observed between the two groups at any time. Conclusion Exclusively outpatient combined techniques were safe and feasible in this study with no major adverse events, despite the large diameters of the GSV or ulcer presence. Within 3 years, both diameter groups showed equivalent improvement in all QOL parameters, satisfactory axial occlusion, and maintained ulcer closure.

show abstract

Section: Discussionmentioning

confidence: 94%

Radiofrequency Ablation for Axial Reflux Associated with Foam Sclerotherapy for Varicosities in One-Step Approach: A Prospective Cohort Study Comprising Large Diameters Saphenous Veins

Poschinger-Figueiredo¹,

Virgini-Magalhães²,

Pôrto³

et al. 2021

VHRM

View full text Add to dashboard Cite

show abstract

“…The early activities after the operation and the activities of the ankle joint are measures to prevent thrombosis. However, there were some reports on the relationship between DVT and the amount of foam 12,13 . Toniolo et al .…”

Section: Discussionmentioning

confidence: 99%

“…However, there were some reports on the relationship between DVT and the amount of foam. 12,13 Toniolo et al reported that 5-35 mL (median 14 mL) foam was used during the course of sclerotherapy, and nine cases of posterior tibial venous thrombosis and seven cases of other partial venous thrombosis occurred, accounting for 1.8% and 1.4% of the 489 patients. 13 The amount of foam used in this study was adjusted and limited according to European guidelines.…”

Section: Discussionmentioning

confidence: 99%

“…12,13 Toniolo et al reported that 5-35 mL (median 14 mL) foam was used during the course of sclerotherapy, and nine cases of posterior tibial venous thrombosis and seven cases of other partial venous thrombosis occurred, accounting for 1.8% and 1.4% of the 489 patients. 13 The amount of foam used in this study was adjusted and limited according to European guidelines. 4 At the same time, we observed a negative correlation between the volume of foam used and the degree of SSV occlusion.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Ultrasound‐guided foam sclerotherapy for primary small saphenous vein insufficiency

2020

ANZ Journal of Surgery

View full text Add to dashboard Cite

show abstract

“…The rates of recanalization at one year following UGFS has been found to be about 15–20%[22, 25]. One study showed post-procedural partial recanalization rate as 29.1% and complete recanalization as 16% after 6 weeks and even within the cases where complete obliteration had occurred recanalization was present in the quarter of the cases after one year [26]. In a recent meta-analysis comparing outcomes of sclerotherapy and endovenous ablation, the quality of existing evidences comparing effectiveness of ultrasound guided foam sclerotherapy with conventional surgery were found to be low in treatment of short saphenous varicose vein [27].…”

Section: Discussionmentioning

confidence: 99%

Short Term Outcome of Adjunct Foam Sclerotherapy for Varicose Veins in Patients Subjected to RFA at Dhulikhel Hospital, Nepal

Karmacharya

Shrestha

Singh

et al. 2019

International Journal of Vascular Medicine

View full text Add to dashboard Cite

Background Varicose veins are dilated, tortuous, superficial veins usually seen on lower limbs. Various surgical modalities are available for varicose veins including open surgery (Trendelenburg operation), Endovenous Laser Ablation (EVLA), Radiofrequency Ablation (RFA) and Sclerotherapy. The aim of this study is to look for the outcome of adjunct sclerotherapy for varicose veins done as an adjunct with Radio Frequency Ablation. Objective To know the possible outcome regarding benefits and complications of adjunct sclerotherapy with Radio Frequency Ablation. MethodologyWe combined Radio Frequency Ablation of varicose veins with necessary phlebectomy and perforator ligation and performed adjunct sclerotherapy for residual significant varicosities with polidocanol (2%) mixed with 2 ml NS and 2 cc of air (Tessari method) to patients undergoing varicose vein surgery in between 2016 and 2017. Records on complications were enquired immediately following surgery and on 1st follow up done within 3–5 days of the procedure. ResultsAmong 256 limbs subjected to varicose veins surgery 51 limbs were given adjunct sclerotherapy. Among them, five limbs had perivenous spillage with some localized swelling while there was allergic reaction in one patient as immediate postprocedural complication. Nine limbs had painful thrombosed veins during early follow-up. ConclusionsAdjunct sclerotherapy showed complication rate of roughly one tenth and one fifth of the treated cases in immediate and early postoperative follow-up.

show abstract

Vein diameter is a predictive factor for recanalization in treatment with ultrasound-guided foam sclerotherapy

Cited by 8 publications

References 26 publications

Radiofrequency Ablation for Axial Reflux Associated with Foam Sclerotherapy for Varicosities in One-Step Approach: A Prospective Cohort Study Comprising Large Diameters Saphenous Veins

Radiofrequency Ablation for Axial Reflux Associated with Foam Sclerotherapy for Varicosities in One-Step Approach: A Prospective Cohort Study Comprising Large Diameters Saphenous Veins

Ultrasound‐guided foam sclerotherapy for primary small saphenous vein insufficiency

Short Term Outcome of Adjunct Foam Sclerotherapy for Varicose Veins in Patients Subjected to RFA at Dhulikhel Hospital, Nepal

Contact Info

Product

Resources

About